Last quarter (Q4 2022), Primary Health Properties plc R.E.I.T's total revenue was £―, a decrease of ― from the same quarter last year. In Q4, Primary Health Properties plc R.E.I.T's net income was £―. See Primary Health Properties plc R.E.I.T’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	-	£ 169.80M	£ 121.70M	£ 222.70M	£ 128.60M	£ -46.50M
Credit Losses Provision	-	-	-	-	-	-
Non Interest Expense	-	-	£ 64.80M	-	-	-
Incomefrom Associatesand Other Participating Interests	-	-	-	-	-	-
Special Income Charges	-	-	£ -45.50M	-	£ 0.00	£ -10.20M
Pretax Income	-	£ 26.10M	£ 56.90M	£ 141.60M	£ 112.40M	£ -70.20M
Tax Provision	-	£ -1.20M	£ 600.00K	£ 1.50M	£ 400.00K	£ 1.10M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	-	£ 27.30M	£ 56.30M	£ 140.10M	£ 112.00M	£ -71.30M
Basic EPS	-	£ 0.02	£ 0.07	£ 0.11	£ 0.09	£ -0.07
Diluted EPS	-	£ 0.02	£ 0.06	£ 0.10	£ 0.09	£ -0.07
Basic Average Shares	-	£ 1.34B	£ 1.33B	£ 1.35B	£ 1.27B	£ 1.09B
Diluted Average Shares	-	£ 1.45B	£ 1.44B	£ 1.45B	£ 1.37B	£ 1.09B
Dividend Per Share	-	£ 0.07	£ 0.07	£ 0.06	£ 0.06	£ 0.06
Reported Normalized Basic E P S	-	-	-	-	£ 0.06	£ 0.06
Reported Normalized Diluted E P S	-	-	-	-	£ 0.06	£ 0.05
Rent Expense Supplemental	-	-	-	-	£ 7.80M	£ 5.60M
Interest Income After Provision For Loan Loss	-	-	£ 154.10M	-	-	-
Net Income From Continuing And Discontinued Operation	-	£ 27.30M	£ 56.30M	£ 140.10M	£ 112.00M	£ -71.30M
Normalized Income	-	£ 25.40M	-	£ 114.70M	£ 60.78M	£ -103.38M
Total Money Market Investments	-	-	-	-	-	-
Ebit	-	£ 76.00M	-	-	-	-
Ebitda	-	£ 76.90M	-	-	-	-

Currency in GBP

Primary Health Properties plc R.E.I.T Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing